Hirosaki Medical Journal
Online ISSN : 2434-4656
Print ISSN : 0439-1721
Original Article
Is analysis of exhaled breath condensate an equivalent to bronchoalveolar lavage fluid in sarcoidosis patients?
Kunihiko Nakamura Megumi MikuniyaShingo TakanashiAkihito HayashiTakeshi MorimotoKageaki TaimaJunichi DempoyaKen Okumura
Author information
JOURNAL FREE ACCESS

2012 Volume 63 Issue 1 Pages 12-20

Details
Abstract

Introduction: Although analysis of bronchoalveolar lavage fluid (BALF) is a useful examination to assess airway inflammation, it is an invasive technique with limitation and risk of complications.
Objectives: The aim of this study was to examine molecules in exhaled breath condensate (EBC) in comparison with BALF, and to clarify the clinical usability of EBC.
Methods: EBC was collected from sixteen subjects suspected to have sarcoidosis just before BAL. The 40 different inflammatory molecules in EBC and BALF were analyzed by protein array.
Results: BALF levels of 6 molecules including soluble tumor necrosis factor receptor type II (sTNF-RII) and regulated upon activation, normal T cell expressed and secreted (RANTES), and EBC levels of 13 molecules including sTNF-RII and RANTES were significantly correlated with percentage of lymphocyte in BALF (%Lym). We found significant correlations between levels of EBC and BALF in 16 out of 40 molecules. Levels of macrophage colony-stimulating factor (M-CSF), RANTES, TNF-α and sTNF-RII in EBC were significantly correlated with BALF. Their levels in EBC and BALF also were correlated with %Lym.
Conclusion: Protein array, a highly sensitive approach allowed us to detect inflammatory molecules in EBC. Comprehensive analysis of EBC might be an equivalent to that of BALF.

Content from these authors
© 2012 Hirosaki Medical Journal Editorial Board
Previous article Next article
feedback
Top